Enzyme linked immunosorbent assay for beta-endorphin in human plasma

Area of Science:

• Biochemistry
• Immunology
• Endocrinology

Background:

• Beta-endorphin (beta-EP) is a key endogenous opioid peptide with diverse physiological roles.
• Accurate quantification of beta-EP in biological samples is crucial for research and clinical applications.

Purpose of the Study:

• To develop and validate a highly sensitive and specific assay for measuring beta-endorphin (beta-EP).
• To determine beta-EP-like immunoreactivity levels in human plasma using the developed assay.

Main Methods:

• Established a double-antibody enzyme-linked immunosorbent assay (ELISA) using beta-D-galactosidase-labeled beta-EP.
• Employed a competitive reaction format with delayed addition of labeled antigen.
• Separated bound and free antigen using an anti-rabbit immunoglobulin G coated immunoplate and fluorometric detection.
• Validated the assay with high-performance liquid chromatography (HPLC) for plasma sample analysis.

Main Results:

• The assay demonstrated high sensitivity with a minimal detection limit of approximately 0.4 fmol/well (10 pmol/l).
• Quantified beta-EP-like immunoreactivity (-LI) in extracted human plasma from normal subjects at 2.44 +/- 0.68 pmol/l.
• HPLC analysis confirmed a single beta-EP immunoreactive form in normal plasma, consistent with synthetic beta-EP.

Conclusions:

• A robust and sensitive ELISA for beta-endorphin (beta-EP) has been successfully developed.
• The assay provides reliable measurement of beta-EP-like immunoreactivity in human plasma.
• This method facilitates further investigation into the physiological and pathophysiological roles of beta-EP.